Understand and fulfil our customers ’ requirements

Continuously engage and delight our customers and stakeholders

Provide a high standard of service to internal and external customers , with teamwork being the essence of our success

Duopharma ’ s Sustainability-led Business Commitment .

Nurture a culture of excellence , resourcefulness and innovation

Continuously improve our processes , products and services

Adhere to the concept of prevention by Doing It Right First Time , Every Time

Ensure that our suppliers are similarly commited to quality improvement

Source : Sustainability Report 2019

management and effective management of sustainability practices . Fourthly , there will also be a Medical Advisory Committee formed in due course to advise the Board on medical , clinical and product developmentrelated matters .

Are there any other essential elements included under Duopharma Biotech ’ s Medical Advisory Committee ? Other essential elements included under the Committee are the compliance to regulatory requirements , Employee Learning and Development , Occupational Safety and Health , Waste Reduction and Management , the Clinical Studies Pharmacovigilance , and Manufacturing and Supply Chain Management . The succession planning and talent development programmes are critical as we are expanding rapidly , and need to ensure our human capital needs are well-addressed .

What are Duopharma ’ s expansion plans for 2020 and beyond ? Are you eyeing new export markets , especially in halal products ? Consumers are increasingly connected to halal-certified products as the preferred choice . It provides a sense of assurance on the quality , especially for the Muslim consumers and mark of hygiene for others of different faiths . I believe the value in halal pharmaceuticals is yet to be fully understood .

We are working with various stakeholders to penetrate specific markets in Southeast Asia with halal pharma as a

differentiator . Therefore , it is an essential feature for us , especially for our Consumer Healthcare products . We recently set up a new subsidiary to manage our Consumer Healthcare business ( or better known as Over the Counter - OTC ) which already contributes just under 20 per cent of total revenue .

We are pushing this segment to grow further , given recent successes on new launches of our OTC brands i . e . Flavettes , Uphamol , Proviton , Eyeglo , etc . We also see great potential for our halal products for the European Union and Middle-East markets .

What in your view needs to be done to attract pharmaceutical companies to make Malaysia a hub for such companies ? I believe there are already several pharmaceutical companies looking at Malaysia as their hub for halal products . It is because a comprehensive eco-system has been established and the attractive halal incentives offered by Halal Development Corporation ( HDC ) and the Malaysia Investment Development Authority ( MIDA ) are in place .

The continuous commitment by the government to further develop the halal industry , specifically the pharma industry , through policies , attractive incentives , human capital development for specific jobs , vibrant Research , Development & Commercialisation , would send a signal to all industry players that Malaysia is still the global champion for halal .

You are a well-respected veteran in the

Siti Sa ' diah joined Duopharma Biotech in 2015 .

healthcare industry with more than 40 years of experience . How has your journey been ? I ’ ve been involved in the healthcare industry for a long time . But all the years of experience is on the demand side of the industry – healthcare services . I ’ ve been involved in the hospital from the setting up of KPJ , the first hospital in 1979 and I left the executive post end 2012 . But I continued to be a corporate advisor for two years . That time I was non-independent . After that , I served as an independent until I left KPJ on March 31 this year . I got involved from the start of the first hospital and when I left , we had about 28 hospitals .

I joined Duopharma Biotech in 2015 . At that time , it was under CCM Berhad . I joined both companies – as the Director of CCM Berhad as well as CCM Duopharma Berhad ,